Prosthetic valve delivery system

Information

  • Patent Grant
  • 12053371
  • Patent Number
    12,053,371
  • Date Filed
    Tuesday, August 31, 2021
    3 years ago
  • Date Issued
    Tuesday, August 6, 2024
    4 months ago
Abstract
A delivery system for delivering a spiral anchor to a diseased native valve of a heart includes an anchor control catheter and an anchor guide extending from the anchor control catheter. The anchor guide includes a flexible configuration and a rigid configuration. The anchor guide in the rigid configuration includes a proximal section, a middle section, and a distal section. The proximal section includes a straight central axis and extends from the anchor control catheter, the middle section spirals axially and radially outwards from the central axis, and the distal section curves concentrically about the central axis in a plane that is perpendicular to the central axis.
Description
INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.


BACKGROUND

Blood flow between heart chambers is regulated by native valves—the mitral valve, the aortic valve, the pulmonary valve, and the tricuspid valve. Each of these valves are passive one-way valves which open and close in response to differential pressures. Patients with valvular disease have abnormal anatomy and/or function of at least one valve. For example, a valve may suffer from insufficiency, also referred to as regurgitation, when the valve does not fully close and allows blood to flow retrograde. Valve stenosis can cause a valve to fail to open properly. Other diseases may also lead to dysfunction of the valves. While medications may be used to treat the disease, in many cases the defective valve may need to be repaired or replaced at some point during the patient's lifetime. Existing valves and surgical repair and/or replacement procedures may have relatively high risks, limited lifespans, and/or be highly invasive. Some less-invasive transcatheter options are available, however these generally are limited to aortic valve procedures, are limited in patient-to-patient flexibility, and often take longer than is desirable to implant. It would therefore be desirable to provide a less invasive procedure for repair and replacement of heart valves, including the mitral valve, quicker surgical methods, and/or prosthetic valves that can accommodate a variety of individual patients.


Additionally, existing valve repair/replacement procedures are often complicated and time-consuming. Presently-available procedures often require the placement of more than one component—for example, a prosthetic valve and a mechanism to anchor it to the native anatomy. Such procedures generally utilize multiple delivery catheters to carry the various components and delivery of each component separately to the valve, which can be time-consuming (particularly if components are delivered sequentially), complicated, and/or dangerous. For example, some devices provide rotational anchoring elements to capture the native anatomy such as the chordae tendineae in order to reduce delivery time. However, such anchoring elements, often by design, capture and pull the chordae along during their rotation, which can torque or otherwise stress and damage the chordae during deployment of the anchor elements, resulting in the need for additional medical interventions for the patient. Moreover, such anchoring elements may require extrusion from a low-profile (e.g., elongated) delivery configuration to an expanded configuration at or near the native valve. In at least some instances, extrusion of the anchoring elements can be complicated and may not reliably deploy into the correct expanded configuration relative to the delivery device and/or the native anatomy. Incorrect deployment may result in additional time to retract and re-deploy the anchoring element, more complicated anchoring procedures, and/or damage to the native tissue. It would therefore be desirable to provide quicker, less-complicated, less dangerous, and more reliably deployable valve assemblies for valvular replacement and repair.


SUMMARY OF THE DISCLOSURE

In general, in one embodiment, a delivery system for delivering a spiral anchor to a diseased native valve of a heart includes an anchor control catheter and an anchor guide extending from the anchor control catheter. The anchor guide includes a flexible configuration and a rigid configuration. The anchor guide in the rigid configuration includes a proximal section, a middle section, and a distal section. The proximal section includes a straight central axis and extends from the anchor control catheter, the middle section spirals axially and radially outwards from the central axis, and the distal section curves concentrically about the central axis in a plane that is perpendicular to the central axis.


This and other embodiments can include one or more of the following features. The anchor guide can include a plurality of cuts configured to define a shape of the guide in the rigid configuration. The plurality of cuts can include window cuts, interlocking spiral cuts, or toothed wedge cuts. The delivery system can further include one or more actuation elements configured to actuate the guide from the flexible configuration to the rigid configuration. The one or more actuation elements can include a nested concentric shaft mechanism or one or more pullwires or cables. The anchor guide can include an intermediate shape-set configuration configured to bias or urge the anchor guide towards the rigid configuration. The anchor guide can include a shape memory material. The anchor guide can include a central channel configured to hold an anchor therein. The anchor guide can be configured to deflect the anchor positioned within the central channel when the anchor guide is transitioned from the flexible configuration to the rigid configuration. The anchor guide can be configured to position the anchor concentrically relative to a central axis of the anchor control catheter. The anchor guide in the flexible configuration can be configured to be positioned within a delivery sheath.


In general, in one embodiment, a method of delivering a valve prosthesis to a diseased native valve of a heart includes positioning a delivery catheter in a first chamber of the heart, actuating an anchor guide of the delivery catheter from a flexible configuration to a rigid configuration, releasing an anchor from within the anchor guide, moving the delivery catheter from the first chamber to a second chamber of the heart such that the anchor guide in the rigid configuration is within the second chamber and the anchor is positioned concentrically relative to central axis of the delivery device, and rotating the anchor guide in the rigid configuration about the central axis so as to rotate the anchor and encircle chordae of the native heart with the anchor.


This and other embodiments can include one or more of the following features. The method can further include delivering a valve frame within the anchor after the step of rotating the anchor guide. Delivering the valve frame can include delivering the valve frame from a separate valve delivery catheter. A distal section of the anchor guide can curve concentrically relative to the central axis when the anchor guide is in the rigid configuration. Releasing the anchor can include releasing the anchor concentrically relative to the central axis. The method can further include adjusting a placement of the anchor with the anchor guide after the step of rotating the anchor guide. Adjusting the placement can include placing torque on the anchor with the anchor guide. Adjusting the placement can include moving the anchor proximally towards a valve annulus with the anchor guide. The diseased native valve can be a mitral valve, the first chamber can be an atrium, and the second chamber can be a ventricle. The method can further include counter-rotating the anchor guide during the step of moving the delivery catheter from the first chamber to the second chamber. An entirety of the anchor can be positioned within the second chamber and not the first chamber after the step of moving the delivery catheter from the first chamber to the second chamber. Releasing the anchor from within the anchor guide can include releasing the anchor while the anchor guide is in the rigid configuration. Releasing the anchor from within the anchor guide can include releasing the anchor while the anchor guide is an intermediate shape set configuration, and the releasing step can occur before the step of actuating an anchor guide of the delivery catheter from a flexible configuration to a rigid configuration.


In general, in one embodiment, a delivery system for delivering a spiral anchor to a diseased native valve of a heart includes an anchor control catheter and an anchor guide extending from the anchor control catheter. The anchor guide has a flexible configuration and a rigid configuration. The anchor guide in the rigid configuration includes a proximal section, a middle section, and a distal section. The proximal section extends from the anchor control catheter, the middle section includes an inversion, and the distal section is concentrically wrapped about the proximal section.


This and other embodiments can include one or more of the following features. The anchor guide can include a plurality of cuts configured to define a shape of the guide in the rigid configuration. The plurality of cuts can include window cuts, interlocking spiral cuts, or toothed wedge cuts. The delivery system can further include one or more actuation elements configured to actuate the guide from the flexible configuration to the rigid configuration. The one or more actuation elements can include a nested concentric shaft mechanism or one or more pullwires or cables. The anchor guide can include an intermediate shape-set configuration configured to bias or urge the anchor guide towards the rigid configuration. The anchor guide can include a shape memory material. The anchor guide can include a central channel configured to hold an anchor therein. The anchor guide can be configured to deflect the anchor positioned with the central channel when the anchor guide transitions from the flexible configuration to the rigid configuration. The anchor guide can be configured to position the anchor concentrically relative to a central axis of the anchor delivery catheter. The anchor guide in the flexible configuration can be configured to be positioned within a delivery sheath. The delivery system can further include an outer sheath positioned over the anchor control catheter and configured to house a prosthetic valve therein. The outer sheath can be configured to be retracted proximally to allow the prosthetic valve to self-expand around the anchor guide.


In general, in one embodiment, a method of delivering a valve prosthesis to a diseased native valve of a heart includes positioning a delivery catheter in a first chamber of the heart, actuating an anchor guide of the delivery catheter from a flexible configuration to a rigid configuration, releasing an anchor from within the anchor guide while the anchor guide is in the rigid configuration, moving the delivery catheter from the first chamber to a second chamber of the heart such that the anchor guide is inverted within the second chamber and the anchor is positioned concentrically around the delivery catheter, and rotating the anchor guide so as to rotate the anchor and encircle chordae of the native heart with the anchor.


This and other embodiments can include one or more of the following features. The method can further include delivering a valve frame within the anchor after the step of rotating the anchor guide. Delivering the valve frame can include delivering the valve frame from within the delivery catheter. Delivering the valve frame can include delivering the valve frame from a separate valve delivery catheter. A distal section of the anchor guide can wrap concentrically about a proximal section of the anchor guide when the anchor guide is in the rigid configuration. Releasing the anchor can include releasing the anchor concentrically relative to the delivery catheter. The method can further include adjusting a placement of the anchor with the anchor guide after the step of rotating the anchor guide. Adjusting the placement can include placing torque on the anchor with the anchor guide. Adjusting the placement can include moving the anchor proximally towards a valve annulus with the anchor guide. The diseased native valve can be a mitral valve, the first chamber is an atrium, and the second chamber is a ventricle. The method can further include counter-rotating the anchor guide during the step of moving the delivery catheter from the first chamber to the second chamber. An entirety of the anchor can be positioned within the second chamber and not the first chamber after the step of moving the delivery catheter from the first chamber to the second chamber.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIGS. 1A-1C illustrates a delivery system including an inverted anchor guide.



FIGS. 2A-2H show an embodiment of a method of delivering an anchor and a valve prosthesis near a native valve annulus using an inverted guide and a single valve delivery catheter.



FIGS. 3A-3X show an embodiment of a method of delivering an anchor and a valve prosthesis near a native valve annulus using an inverted guide and a single valve delivery catheter.



FIGS. 4A-K shown embodiment of a method of delivering an anchor and valve prosthesis near a native valve annulus using an anchor delivery catheter with an inverted guide and a separate valve delivery catheter.



FIG. 5A shows an inverted anchor guide for use with a single catheter delivery system.



FIG. 5B shows an inverted anchor guide for use with a double catheter delivery system.



FIG. 6 shows a portion of an anchor guide including a toothed wedge cut.



FIGS. 7A-7I show another embodiment of an anchor guide.



FIGS. 8A-8M show an embodiment of a method of delivering an anchor using an anchor guide similar to that shown in FIGS. 7A-7I.



FIGS. 9A-9C show a flat spiral anchor deployed from an anchor guide similar to that shown in FIGS. 7A-7I.



FIG. 10A shows an intermediate geometry shape set of an anchor guide. FIG. 10B shows the anchor guide of FIG. 10A in the deployed configuration.



FIGS. 11A-11B show a concentric actuation mechanism for an anchor guide.



FIGS. 12A-12B show the exemplary attachment of an anchor control catheter to an anchor guide.



FIGS. 13A-13B show a comparison of the effects of a cut pattern without curved window cuts (FIG. 13A) to the effects of a cut pattern with curved window cuts (FIG. 13B).





DETAILED DESCRIPTION

Described herein are devices and methods for use in delivering a valve prosthesis, including an anchor and/or frame, for example during a mitral valve replacement.



FIGS. 1A-1C depict a delivery system 2200 including an anchor guide 1000 configured in accordance with embodiments of the present disclosure. The anchor guide 1000 may form a portion of an anchor control catheter 122 (e.g., can be coupled with a distal portion of the anchor control catheter 122). Further, in some embodiments, the delivery system 2200 can include an outer sheath 108 configured to extend over the anchor control catheter 122 and/or the guide 1000.


In some embodiments, the anchor guide 1000 can be formed of a hypotube, such a hypotube having a plurality of slits or cuts 1010 therein (see FIG. 1B). The cuts 1010 can, for example, be formed using a laser cut pattern. In some embodiments, the cuts 1010 can be window cuts (for enhanced flexibility), interlocking spiral cuts (e.g., that enable a flexible configuration without compression and a rigid straight configuration when under compression), and/or toothed wedge cuts (e.g., that enable a flexible configuration when not under compression and a rigid bent configuration whereby neighboring edges of the cuts 1010 engage or lock when under compression). An exemplary portion of a guide 1000 including toothed wedge cuts 1010 is shown in FIG. 6. The anchor guide 1000 can further include a spine (i.e., a continuous section extending an entire length of the guide 1000 that does not include any cuts therein).


In some embodiments, the anchor guide 1000 is configured to couple with, and be actuated by, one or more actuation elements (e.g., pullwires or cables). Actuation of the anchor guide 1000 with the more actuation elements may transition the anchor guide 1000 from a first configuration (e.g., that enables placement of the anchor guide 1000 within the outer sheath 108) to a second configuration (e.g., that is adapted to manipulate and position an anchor within the heart). As shown in FIG. 1B, for example, the anchor guide 1000 can include a first actuation element that terminates at a first termination point 1011 and a second actuation element that terminates at a second termination point 1012. The stiffness of the anchor guide 1000 can increase as the anchor guide 1000 transitions from the first configuration to the second configuration. The anchor guide 1000 in the second configuration can advantageously have a stiffness sufficiently high to deflect the anchor within the guide 1000 and to support and guide the anchor during delivery.


In some embodiments, the anchor guide 1000 may at least partially self-assemble, for example, using a shape memory effect. As used herein, self-assembly is a process in which a component transitions from a first configuration to a second configuration, without external application of force or direction. In some embodiments, the anchor guide 1000 may have a shape set geometry (e.g., via heat treatment) that is an intermediate geometry, e.g., a geometry that is in between the first configuration (e.g., straight) geometry and the second configuration (e.g., fully curved) geometry. The intermediate shape set geometry can reduce strain within the anchor guide 1000, for example, with respect to a strain induced by the first configuration and/or the second configuration geometry. By having an intermediate shape set that is between the first and second configurations, the strain in the anchor guide 1000 can be reduced as it transitions from the first configuration to the second configuration. For example, the anchor guide 1000 may have a (−) 3% strain in a specific region to obtain the first configuration and a (+) 3% strain to obtain the second configuration rather than 6% strain if shape set were at either of the end point configurations. The intermediate shape set geometry can further bias or urge the anchor guide 1000 to transition toward the second configuration from the first configuration as the anchor guide 1000 is deployed. The anchor guide 1000 may be formed of any of the materials described herein—for example, of a shape memory material (e.g., nitinol).


The anchor guide 1000 can include a plurality of sections 1001-1006 that may provide distinct features and/or functions for the anchor guide 1000 (e.g., during deployment of the anchor control catheter 122 and/or of the anchor). The anchor guide 1000 in the first configuration may be substantially straight or elongate (as shown in FIG. 1B) so as to fit within a delivery catheter. Once deployed in the heart, the anchor guide 1000 may assume the second configuration (as shown in FIG. 1A) and therefore take on a three-dimensional curved shape. When the anchor guide 1000 is in the second configuration, the distal section 1006 may be concentrically wrapped about and positioned above (superior to) a proximal section 1001 of the anchor guide 1000. Further, when the anchor guide 1000 is in the second configuration, the middle section 1003 may include an inversion. At times, the anchor guide 1000 may be referred to herein as an “inverted” anchor guide 1000.


Section 1001 can be the proximal-most section and can be configured to bond (e.g., thermally bond) to the distal portion of the anchor control catheter. Section 1001 can further include a plurality of window cuts (see FIG. 1B) therein to create enhanced flexibility. In some embodiments, the flexibility of section 1001 can be substantially equivalent to the flexibility of the anchor control catheter.


Section 1002, in turn, can include a plurality of aligned toothed wedge cuts 1010 having substantially equivalent lengths. The bending of section 1002 (towards the cuts) can be controlled by the first actuation element (that terminates at first termination point 1011) while the bending of the rest of the sections 1003-1006 can be controlled by the second actuation element (that terminates at the second termination point 1012). Because the bending of section 1002 is controlled by a separate actuation element from the rest of the sections, the bending section 1002 can be used to alter the planarity of the anchor 114 and/or guide 1000 during delivery of the anchor 114 (e.g., during encircling of the chordae).


Section 1003 can be configured as the inversion section (e.g., can include a u-shaped bend in the second configuration, such as a bend transitioning in direction through 160°-200°, such as 170°-190°, such as approximately 180°). In some embodiments, section 1003 can have an intermediate shapeset to reduce strain and/or to bias the section 1003 towards the desired curvature. Section 1003 can include a plurality of aligned toothed wedge cuts 1010 having substantially equivalent lengths. The toothed wedge cuts 1010 of section 1003 can be circumferentially offset (e.g., by approximately 90 degrees) from the toothed wedge cuts 1010 of section 1002.


Section 1004 can be a substantially straight section having a plurality of interlocking spiral cuts 1010. Section 1004 can be substantially rigid and straight with minimal compression in the second configuration and flexible in the first configuration (e.g., when no force is applied by the actuation element).


Section 1005 in the second configuration can have a twist along a curve that is tangent to the proximal section 1004 and/or to the distal end of section 1006. Section 1005 can include a plurality of toothed wedge cuts 1010 arranged in a spiral pattern and can further include an intermediate shapeset.


Finally, distal section 1006 can be configured to support and guide the anchor during encircling and/or valve deployment. The distal section 1006 in the second configuration can curve substantially in-plane and along the same axis as the anchor. Section 1005 can further include a plurality of aligned toothed wedge cuts 1010 of substantially equal length and can have an intermediate shapeset.


In some embodiments, the anchor guide 1000 can enable delivery of an anchor and a valve using a single catheter delivery system. For example, FIGS. 2A-2H show a method of delivering an anchor 114 and valve 120 using a single catheter prosthetic valve delivery system 3000. At FIG. 2A, the delivery system 3000 (including the anchor 114 and valve 120 therein) is translated over a wire 109 through a transseptal puncture and into an atrium 104 of a heart. At FIG. 2B, the wire 109 is retracted and an anchor control catheter 122 having an anchor guide 1000 at a distal end thereof is advanced into the atrium 104. The anchor guide 1000 may transition from a flexible first configuration to a rigid second configuration, where the second configuration includes an inverted portion such that a distal end 1115 thereof at least partially wraps concentrically about the delivery system 3000. At FIG. 2C, once the anchor guide 1000 is in the rigid second configuration, the anchor 114 is pushed out through distal tip of the anchor guide 1000, which urges the anchor 114 to wrap concentrically about the valve delivery system 3000. The mechanical properties (e.g., stiffness) and geometry (e.g., curvature) of the anchor guide 1000 can provide torque on the anchor 114 during deployment to enable the anchor 114 to deploy concentrically around the delivery system 3000 as the anchor 114 is released from the anchor guide 1000. In some embodiments, a proximal portion of the anchor 114 can remain partially within the distal tip of the anchor guide 1000 to provide additional control over the anchor 114 as the anchor 114 is placed. At FIG. 2D, the entire delivery system 3000 is pushed and steered (for example, via steering mechanisms in the outer sheath 108) across the mitral annulus and toward an apex of the ventricle 106. In some embodiments, counter-rotation of the anchor 114 (via counter-rotation of anchor control catheter 122 and the anchor guide 1000) may aid in advancing the anchor 114 across the mitral valve without entanglement of the chordae. At FIG. 2E, the anchor 114 has been positioned at a selected depth within the ventricle 106, and forward (e.g., clockwise) rotation of the anchor 114 (via forward rotation of the anchor control catheter 122 and the anchor guide 1000) enables the anchor 114 to encircle the mitral leaflets and chordae. The selected depth of the anchor 114 may be in close proximity to the surface of the annulus, within the ventricle 106. In some embodiments, the anchor 114 placement and encircling is as close to the annulus as can be achieved. In some embodiments, an inverted anchor guide 1000 may advantageously transmit forces to the anchor 114 via the anchor control catheter 122 that urge the anchor 114 toward the annulus and/or maintain anchor planarity during encirclement. For example, the inverted anchor guide 1000 can transmit a pushing force toward the sub-annular space of the ventricle 106, via a pulling force generated at the anchor control catheter 122. Once the anchor 114 has been placed in a selected position about the chordae and/or leaflets, a prosthetic valve 120 may be deployed by retraction an outer sheath 108 of the valve delivery system 3000 (e.g., FIG. 2F). In some embodiments, deployment of the prosthetic valve 120 is performed while the anchor guide 1000 maintains a selected position of the anchor 114. In some embodiments, the position of the anchor guide 1000 and/or anchor 114 can be adjusted during and/or following deployment of the prosthetic valve 120 (e.g., by torquing or otherwise moving the anchor guide 1000 while the anchor guide 1000 is in the rigid configuration). At FIG. 2G, the anchor 114 is released from the valve delivery system 3000 and the anchor control catheter is proximally retracted. At FIG. 2H, the valve delivery system 3000 is retracted from the heart with the prosthetic valve 120 and anchor 114 remaining implanted.



FIGS. 3A-3X depict a more detailed example of deploying a prosthetic valve to a heart using a single catheter delivery system 3000 with guide 1000. At FIG. 3A, the wire 109 can be placed through a transseptal puncture into the atrium 104 and/or ventricle 106. At FIGS. 3B and 3C, the delivery system 3000 can be translated over the wire 109 into the atrium 104. At FIGS. 3D and 3E, the wire 109 can be retracted. At FIG. 3F, the anchor guide 1000 can be advanced out of the outer sheath 108 and into the atrium 104. At FIG. 3G, the anchor guide 1000 can be further advanced out of the outer sheath 108 and begin to invert (e.g., due to self-assembly). At FIG. 3H, the anchor guide 1000 can be completely advanced out of the outer sheath 108 and transitioned fully from the first configuration to the inverted and rigidized second configuration (e.g., via self-assembly and/or activation of the actuation elements). At FIGS. 3I-3K, the anchor 114 can be advanced out of the anchor guide 1000. At FIG. 3L, the delivery system 3000 can then be advanced so as to move the anchor 114 and the anchor guide 1000 into the ventricle 106. In some embodiments, the anchor guide 1000 can be counter-rotated as the delivery system 3000 is advanced so as to prevent the anchor 114 and/or guide 1000 from entangling with the chordae. At FIGS. 3M-3N, the anchor guide 1000 can be rotated so as to rotate the anchor 114 around the chordae 114. At FIGS. 3O and 3P, the anchor guide 1000 (still in the rigid configuration) can be torqued or otherwise maneuvered so as to adjust the planarity and/or positioning of the anchor 114 (e.g., so as to push the anchor 114 close to the mitral valve annulus). At FIGS. 3Q-3T, the valve 120 can be released within the anchor 114 by retracting the sheath 108 proximally. At FIG. 3U, the anchor guide 1000 can be transitioned back to the flexible configuration and pulled within the delivery system 3000. At FIGS. 3V-3X, the delivery system 3000 can then be fully removed from the heart, leaving the anchor 114 and valve 120 in place.


Advantageously, the anchor guide 1000 can enable use of a single catheter delivery system 3000 while also ensuring anchor planarity and positioning control. That is, because the anchor guide 1000 can be inverted within the ventricle 104, the valve prosthesis 120 can be positioned radially within, and axially aligned relative to, the anchor 114 while the anchor guide 1000 remains in position. Further, the anchor guide 1000 can be used to specifically and accurately adjust the planarity and position of the anchor 114 both before, during, and after deployment of the prosthetic valve. The anchor guide 1000 can advantageously be relatively flexible in the first (non-actuated) configuration and relatively rigid in the second (actuated) configuration for enhanced control of the anchor 114. The anchor guide 1000 in the second configuration can advantageously both provide support to the anchor 114 during encircling of the anchor 114 and can hold the anchor 114 in the correct location for valve deployment when a single catheter delivery system 3000 is used.


In some embodiments, the anchor guide 1000 can be part of a double catheter delivery system (e.g., a delivery system that includes a catheter for delivery of the anchor and a separate catheter for delivery of the frame). For example, FIGS. 4A-4K show a method of delivering an anchor 114 and valve 120 using a double catheter prosthetic valve delivery system. At FIG. 4A, an anchor delivery catheter 4400 is tracked over a wire 109 through a transseptal puncture into an atrium 104 of the heart. At FIG. 4B, the wire 109 can be removed and an anchor control catheter 122 (with guide arm 1000 at the distal end thereof) can be advanced through the outer sheath 108 until the guide arm 1000 is deployed in the atrium 104 and transitioned fully from the first configuration to the second configuration. At FIG. 4C, the anchor 114 can be deployed through the lumen in the guide arm 1000 such that the anchor 114 wraps concentrically around the anchor delivery catheter 4400. At FIG. 4D, the anchor delivery catheter 4400 and anchor 114 can be pushed and/or steered across the mitral annulus into the ventricle 106. In some embodiments, counter-rotation of the anchor 114 (via counter-rotation of the anchor control catheter 122 and the anchor guide 1000) may aid in advancing the anchor 114 across the mitral valve without entanglement of the chordae. At FIG. 4E, the anchor 114 can be positioned such that the distal tip is in the LVOT, and then the anchor 114 can be rotated (via rotation of the anchor control catheter 122 and the anchor guide 1000) such that the tip travels between the ventricular walls and the leaflets/chordae. At FIG. 4F, the anchor guide 1000 can be retracted such that an inverted loop of tether 118 is left attached to the anchor 114. The anchor delivery catheter 4400 can be completely removed from the patient, leaving only the anchor 114 and tether 118 in position. At FIG. 4G, a valve delivery catheter 4500 can be tracked concentrically over the tether 118. At FIG. 4H, a positioning tool 131 can be deployed through the valve delivery catheter 4500 over the tether 118. A distal end of the positioning tool 131 can engage with a proximal end of the anchor 114, causing the positioning tool 114 to become stiff and holding the anchor 114 in a specific orientation. At FIG. 4I, the positioning tool 114 can be manipulated such that the anchor 114 is lifted higher into the sub-annular space, and the valve delivery catheter 4500 can be manipulated so as to be at the desired deployment height relative to the anchor 114. At FIG. 4J, the valve 120 can be deployed (e.g., by retracting an outer sleeve of the valve delivery catheter). At FIG. 4K, the tether 118 can be released from the anchor 114, the tether 118 and positioning tool 131 can be retracted into the valve delivery catheter 4500, the outer sleeve can be advanced, and the entire valve delivery system 4500 can be removed from the patient.


The anchor guide 1000 can advantageously be relatively flexible in the first (non-actuated) configuration and relatively rigid in the second (actuated) configuration for enhanced control of the anchor 114. Advantageously, the anchor guide 1000 in the second configuration can be used as part of a double catheter delivery system to precisely control placement of the anchor 114 prior to delivery (e.g., as a result of the specific shape and stiffness of the anchor guide 1000 in the second configuration). Further, the anchor guide 1000 in the second configuration can provide support to the anchor during encircling. The bends or curves of the anchor guide 1000 in the second configuration can additionally advantageously be fully inside the ventricle (below the leaflets) during encircling instead of in the intra-annular space, thereby preventing the anchor guide 1000 from interfering with the functioning of the leaflets. Additionally, the anchor guide 1000, because it leaves a tether 118 inverted and concentrically placed within the anchor 114, can advantageously enable concentric delivery of the valve 120 therethrough.


In some embodiments, an inverted anchor guide for use with a single catheter delivery system can be slightly different in configuration and design from an inverted anchor guide for use with a double catheter delivery system. For example, as shown in FIGS. 5A-5B, the anchor guide 1000a for use with a single catheter delivery system can have a longer total axial length than the anchor guide 1000b for use with a double catheter delivery system. For example, any or all of sections 1001-1005 can be longer for the single catheter delivery system than the double catheter delivery system. The longer total length of the anchor guide 1000a for the single catheter delivery system can advantageously accommodate placement of the valve within the anchor/annulus while the shorter length of the anchor guide 1000b for the double catheter delivery system can advantageously provide enhanced control over the anchor (e.g., by shortening the moment arm relative to the anchor).


Although described herein as being actuated by one or more actuation elements such as pullwires or cables, it should be understood that other actuating mechanisms are possible. For example, a concentric actuation mechanism can be used whereby an inner shaft can be pulled proximally relative to the anchor guide 1000 to transition the anchor guide 1000 from the first configuration to the second configuration (e.g., as described with respect to FIGS. 11A-11B). As another example, an outer sleeve can be pulled proximally relative to the anchor guide 1000 to transition the anchor guide 1000 from the first configuration to the second configuration.


Another exemplary anchor guide 2000 is shown in FIGS. 7A-7I. The anchor guide 2000 can be similar to anchor guide 1000, but without the presence of an inversion. Like anchor guide 1000, anchor guide 2000 can be formed of a hypotube, such as a hypotube having a plurality of slits or cuts 2010 therein (see FIGS. 7A, 7C, 7D, and 7I). In some embodiments, the cuts 2010 can be window cuts (for enhanced flexibility), interlocking spiral cuts (e.g., that enable a flexible configuration without compression and a rigid straight configuration when under compression), and/or toothed wedge cuts (e.g., that enable a flexible configuration when not under compression and a rigid bent configuration whereby neighboring edges of the cuts 2010 engage or lock when under compression).


In some embodiments, the anchor guide 2000 is configured to couple with, and be actuated by, one or more actuation elements (e.g., via a concentric actuation member as described with respect to FIGS. 11A-11B). Actuation of the anchor guide 2000 with the one or more actuation elements may transition the anchor guide 2000 from a first configuration (e.g., that enables placement of the anchor guide 2000 within an outer sheath 108) shown in FIG. 7A to a second configuration (e.g., that is adapted to manipulate and position an anchor within the heart) shown in FIGS. 7B-7I. Like anchor guide 1000, the stiffness of the anchor guide 2000 can increase as the anchor guide 2000 transitions from the first configuration to the second configuration. The anchor guide 2000 in the second configuration can advantageously have a stiffness sufficiently high to deflect the anchor 114 within the guide 2000 and to support and guide the anchor 114 during delivery.


In some embodiments, the anchor guide 2000 may at least partially self-assemble, for example, using a shape memory effect. In some embodiments (and as shown in FIG. 10A), the anchor guide 2000 may have a shape set geometry (e.g., via heat treatment) that is an intermediate geometry, e.g., a geometry that is in between the first configuration (e.g., straight) geometry and the second configuration (e.g., fully curved) geometry (as shown in the transition from FIGS. 10A-10B). The intermediate shape set geometry can reduce strain within the anchor guide 2000, for example, with respect to a strain induced by the first configuration and/or the second configuration geometry. By having an intermediate shape set that is between the first and second configurations, the strain in the anchor guide 2000 can be reduced as it transitions from the first configuration to the second configuration. For example, the anchor guide 2000 may have a (−) 3% strain in a specific region to obtain the first configuration and a (+) 3% strain to obtain the second second configuration rather than 6% strain if shape set were at either of the end point configurations. The intermediate shape set geometry can further bias or urge the anchor guide 2000 to transition toward the second configuration from the first configuration as the anchor guide 2000 is deployed. The anchor guide 2000 may be formed of any of the materials described herein—for example, of a shape memory material (e.g., nitinol).


The anchor guide 2000 can include a plurality of sections 2001-2004 that may provide distinct features and/or functions for the anchor guide 2000 (e.g., during deployment of the anchor control catheter and/or of the anchor). The anchor guide 2000 in the first configuration may be substantially straight or elongate (as shown in FIG. 7A) so as to fit within a delivery catheter. Once deployed in the heart, the anchor guide 2000 may assume the second configuration (as shown in FIGS. 7B-7I) and therefore take on a three-dimensional curved shape. When the anchor guide 2000 is in the second configuration, the distal section 2004 may be concentrically wrapped about an axis 2005 that extends through the proximal section 2001. Unlike anchor guide 1000, the distal section 2004 of anchor guide 2000 in the second configuration can remain distal of the proximal section 2001 and can form the distal-most portion of the deployed anchor guide 2000.


Proximal section 2001 can be the proximal-most section and can be configured to bond (e.g., thermally bond) to the distal portion of the anchor control catheter 122. Section 2001 can be substantially straight and axially aligned with a distal end of the anchor control catheter 122. Sections 2002-2004 can all include a spine, a plurality of window cuts (e.g., to reduce friction with the concentric actuation member), and a plurality of toothed wedge cuts (e.g., trapezoidal cuts) to create hard stops to form the final shape (e.g., the second configuration). The cross-section of section 2003 is shown in FIG. 7I. As shown in FIG. 7I, the anchor guide 2000 can include the spine at a first circumferential location (e.g., at 0°), a toothed wedge cut at a second circumferential location (e.g., at 90°), a window cut at a third circumferential location (e.g., at 180°), and another toothed wedge cut at a fourth circumferential location (e.g., at 270°). Referring to FIGS. 13A-13B, having an anchor guide 2000 with window cuts in combination with the toothed wedge cuts (shown in FIG. 13B) can advantageously reduce the amount of constriction in the central lumen of the anchor guide 2000 when the anchor guide is in the rigid configuration relative to an anchor guide without the window cuts (shown in FIG. 13A). The reduction in lumen constriction can advantageously decrease the force for actuation of the anchor guide 2000 from the flexible to the rigid configuration, which can in turn reduce the amount of whipping or degradation caused to the anchor control catheter 122. Further, the reduction in lumen constriction can advantageously reduce friction as the anchor 114 passes through the anchor guide 2000. Finally, having an anchor guide 2000 with window cuts can also advantageously provide clearance for edge treatments (e.g., rounding processing) and/or internal coating or lamination steps, during manufacturing of the anchor guide 2000, which can further help reduce friction as the anchor 114 passes through the anchor guide 2000.


Additionally, each of sections 2002-2004 can have a respective intermediate shape set. Section 2002 can include a plurality of axially aligned cuts and can be configured to curve away axially and radially away from the straight section 2001. Section 2003 can include a plurality of cuts arranged in a spiral pattern such that section 2003 takes on a three-dimensional spiral in the second configuration. Finally, distal section 2004 can include a plurality of axially aligned cuts configured such that section 2004 takes on a flat or planar curve that is concentric with the axis 2005 of section 2001 and that arcs through approximately 150-210 degrees, such as 180 degrees (e.g., so as to hold 180 degrees of the spiral anchor 114 therein). The distal section 2004 can further be positioned within a plane that is perpendicular to the axis 2005 of the proximal section 2001.


In some embodiments, the anchor guide 2000 can be part of a double catheter delivery system (e.g., a delivery system that includes a catheter for delivery of the anchor 114 and a separate catheter for delivery of the valve 120). For example, FIGS. 8A-8M show a method of delivering an anchor 114 with an anchor delivery catheter 8800 such that a valve can be delivered thereafter. At FIG. 8A, an anchor delivery catheter 8800 is tracked (e.g., over a guidewire) through a transseptal puncture into an atrium 104 of the heart, and an anchor control catheter 122 (with guide arm 2000) can begin deployment (e.g., from outer sheath 108) into the atrium 104. At FIG. 8B, the guide arm 2000 can be fully deployed from the sheath 108 into the atrium 104 and transitioned from the first configuration to the second configuration. At FIG. 8C, the anchor 114 can begin to be deployed through the lumen in the guide arm 2000 such that the flat spiral anchor 114 curves within the same plane as the distal section of the guide arm 2000. At FIG. 8D, the anchor 114 can be fully deployed within the atrium 114 such that the anchor 114 wraps concentrically about the proximal section of the guide arm 2000 (and/or the axis of the delivery catheter 8800). At FIG. 8E, the outer sheath 108 can be deflected and/or the anchor control catheter 122 can be translated distally so as to move the deployed anchor 114 towards the mitral valve annulus. At FIG. 8F, the outer sheath 108 can be steered so as to adjust the plane of the anchor 114 to be parallel to the mitral annulus. At FIG. 8G, the anchor 114 and guide 2000 can be translated distally across the mitral valve annulus. In some embodiments, the anchor guide 114 can be counter-rotated (e.g., in a direction such that the distal tip of the anchor guide 2000 trails rotation) while being translated so as to avoid entanglement with the native anatomy. At FIG. 8H, the anchor 114 and guide 2000 can be fully translated (e.g., with additional counter-rotation) into the ventricle 106. At FIG. 8I, the anchor guide 2000 can be rotated forward (starting with the distal tip near the LVOT) such that the tip of the anchor travels between the ventricular walls and the native leaflets/chordae. At FIGS. 8J and 8K, the anchor 114 can be fully encircled via further forward rotation of the anchor guide 2000. At FIG. 8L, the anchor control catheter 122 and guide 2000 can be removed from the patient, leaving a tether 118 in position. A valve can then be delivered within the anchor 114, such as over the tether 118 (e.g., in a similar manner as described with respect to FIGS. 4G-4K).


Advantageously, as shown in FIGS. 9A-9C, the distal section of the anchor guide 2000 can be configured so as to closely match both the curvature and the planarity of (e.g., at least a portion of) the flat spiral anchor 114. This configuration can enable precise placement of the anchor 114 during delivery. Additionally, the anchor guide 2000 can advantageously take up a small axial space in the heart (e.g., less than 25 mm, such as less than 22 mm, such as 21 mm or less), thereby minimizing effects on the local anatomy. The anchor guide 2000 can further advantageously be delivered to the heart via tortuous anatomy when in a flexible configuration and can then be stiffened so as to enable fine control of the anchor 114.


Referring to FIGS. 11A-11B, in some embodiments, the anchor control catheter 122 and guide 2000 can include two shafts (an inner actuation shaft 1111 and an outer torque shaft 1112) that together make up the concentric actuation mechanism. The inner actuation shaft 1111 and outer torque shaft 1112 can be bonded together at the distal end (e.g., via the interlocking teeth shown in FIG. 11A), but free to move relative to one another at the proximal end (shown in FIG. 11B). Thus, as a proximal force is applied to the inner actuation shaft 1111, the cuts in the outer torque shaft 1112 (e.g., in the anchor guide 2000) can begin to compress together, enabling the anchor guide 2000 to take on the second configuration. In some embodiments, the inner actuation shaft 1111 can be made of a tungsten coil over a liner, a braid over a coil, or a Pebax lamination. In some embodiments, the proximal portion of the outer torque shaft 1112 can be made of stainless steel while the distal portion of the outer torque shaft 1112 (making up the anchor guide 2000) can be made of nitinol. Although described herein as being actuated by a concentric actuation mechanism, it should be understood that other actuation mechanisms can be use for anchor guide 2000. For example, a plurality of pullwires can be used to actuate (as described with respect to anchor guide 1000) the anchor guide 2000. As another example, an outer sleeve can be pulled proximally relative to the anchor guide 2000 to transition the anchor guide 2000 from the first configuration to the second configuration.


Referring to FIGS. 12A-12B, the anchor guides 1000/2000 described herein and the anchor control catheter 122 can be bonded together via interlocking features configured to transfer torque for rotation of the anchor guide 1000/2000. For example, as shown in FIG. 12A, the proximal section of the anchor guide 1000/2000 can include an L-shaped notch therein configured to interlock with a radial extension on the anchor control catheter 122. The joint can then be bonded together. As another example and as shown in FIG. 12B, the anchor guide 1000/2000 can include a notch configured to engage with a corresponding notch on the anchor control catheter 122, and the joint can then be bonded together.


Advantageously, the anchor guides 1000/2000 described herein enable the anchor 114 to be positioned concentric to the axis of rotation of the anchor control catheter 122, thereby enabling the anchor to rotate concentrically about the native chordae when the anchor control catheter 122 is rotated.


Although the anchor guides 1000/2000 are described herein as transitioning from the first to the second configuration after exiting the sheath 108 and before deployment of the anchor 114, other sequences of steps are possible. For example, in one method, the anchor 114 may be deployed from the anchor guide 1000/2000 while the anchor guide 1000/2000 is in an intermediate configuration (i.e., between the first and second configurations). For example, the anchor 114 can be deployed from the anchor guide 1000/2000 while it is in an intermediate shape set configuration. The anchor guide 1000/2000 can then be fully transitioned to the second configuration when the anchor 114 has been partially or fully deployed from the anchor guide 1000/2000. Having the anchor 114 deployed from the anchor guide 1000/2000 while the anchor guide 1000/2000 is in the intermediate shape set configuration may advantageously reduce friction on the anchor 114 as the anchor 114 moves through the anchor guide 1000/2000 while also advantageously directing the anchor 114 to wrap around the anchor guide 1000/2000 (e.g., for concentric positioning when the anchor guide 1000/2000 is in the second configuration).


Additional delivery system features are described in International Application No. PCT/US2020/023671, filed on Mar. 19, 2020, titled “PROSTHETIC CARDIAC VALVE DEVICES, SYSTEMS, AND METHODS,” now PCT Publication No. WO 2020/191216 and in International Application No. PCT/US2021/040623, filed on Jul. 7, 2021, titled “VALVE DELIVERY SYSTEM,” the entirety of which is incorporated by reference herein.


The anchor described herein can be a spiral anchor (e.g., a flat spiral anchor). The anchor can be configured to extend around the chordae of the valve (e.g., the mitral valve) and around the valve prosthesis to hold the valve prosthesis in place. Exemplary anchors are described in International Application No. PCT/US2019/068088, filed on Dec. 20, 2019, titled “PROSTHETIC CARDIAC VALVE DEVICES, SYSTEMS, AND METHODS,” now PCT Publication No. WO 2020/132590, the entirety of which is incorporated by reference herein. In some embodiments, the anchor can have a proximal end (e.g., the end configured to engage with the delivery system) that is substantially in the plane of the annulus or is pointed down into the ventricle.


The valve prosthesis described herein can be similar to those of existing transcatheter-delivered valves. The valve prosthesis can be similar to existing surgical tissue valves, and mechanical valves. At least a portion of the valve segment may be positioned within at least a portion of the valve prosthesis, for example with a frame structure of the valve prosthesis. The valve segment may include leaflets formed of multi-layered materials for preferential function. The valve segment may comprise at least one leaflet having an inner layer and an outer layer. The valve segment may be attached directly to the valve prosthesis. Alternatively, the valve segment may be attached to an intermediate valve structure that is in turn connected to the valve prosthesis. The valve segment may be connected to the valve prosthesis before or after the valve prosthesis has been deployed adjacent a native valve. The valve prosthesis may be attached to a leaflet of the valve segment, for example an outer layer of a leaflet, at one or more ends of the valve prosthesis. The valve prosthesis may be attached to a leaflet of the valve segment, for example an outer layer of a leaflet, at one or more intermediate portions of the valve prosthesis. The valve segment may comprise a plurality of leaflets. The valve segment may comprise a biocompatible one-way valve. Flow in one direction may cause the leaflet(s) to deflect open and flow in the opposite direction may cause the leaflet(s) to close.


The frame structure may be configured like a stent. The frame structure may, for example, comprise a scaffold in a diamond pattern formed from a shape memory material (e.g., nitinol, NiTi). One of ordinary skill in the art will appreciate that many other structures, materials, and configurations may be employed for the frame structure. For example, the frame structure may be formed of a polymer of sufficient elasticity. The frame structure may be formed of a combination of metal and polymer, such as metal (e.g., shape memory material) covered in polymer. The frame structure may include a variety of patterns besides diamond shapes. In some embodiments, the frame structure is a closed frame such that blood flow is forced through valve segment therein. One or more skirts and/or seals may help force blood through the valve segment. Exemplary frame structures and valve prostheses are described in International Application No. PCT/US2020/027744, filed on Apr. 10, 2020, titled “MINIMAL FRAME PROSTHETIC CARDIAC VALVE DELIVERY DEVICES, SYSTEMS, AND METHODS,” now PCT Publication No. WO 2020/210685, the entirety of which is incorporated by reference herein.


One of ordinary skill in the art will recognize based on the description herein that any of the valve prostheses described herein may comprise any of the frame structure shapes, frame structure designs, frame structure materials, anchor shapes, anchor windings, anchor materials, free end tips, leaflet(s) configurations, or any other of the variable features described herein in any combination thereof as desired.


It should be understood that any feature described herein with respect to one embodiment may be combined with or substituted for any feature described with respect to another embodiment.


When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected,” “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected,” “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.


Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a,” “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.


Spatially relative terms, such as “under,” “below,” “lower,” “over,” “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly,” “downwardly,” “vertical,” “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.


Although the terms “first” and “second” may be used herein to describe various features/elements (including steps), these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.


Throughout this specification and the claims which follow, unless the context requires otherwise, the word “comprise,” and variations such as “comprises” and “comprising” means various components can be co-jointly employed in the methods and articles (e.g., compositions and apparatuses including device and methods). For example, the term “comprising” will be understood to imply the inclusion of any stated elements or steps but not the exclusion of any other elements or steps.


As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), or +/−10% of the stated value (or range of values). Any numerical values given herein should also be understood to include about or approximately that value, unless the context indicates otherwise. For example, if the value “10” is disclosed, then “about 10” is also disclosed. Any numerical range recited herein is intended to include all sub-ranges subsumed therein. It is also understood that when a value is disclosed that “less than or equal to” the value, “greater than or equal to the value” and possible ranges between values are also disclosed, as appropriately understood by the skilled artisan. For example, if the value “X” is disclosed the “less than or equal to X” as well as “greater than or equal to X” (e.g., where X is a numerical value) is also disclosed. It is also understood that the throughout the application, data is provided in a number of different formats, and that these data represent endpoints and starting points, and ranges for any combination of the data points. For example, if a particular data point “10” and a particular data point “15” are disclosed, it is understood that greater than, greater than or equal to, less than, less than or equal to, and equal to 10 and 15 are considered disclosed as well as between 10 and 15. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.


Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.


The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.

Claims
  • 1. A delivery system for delivering a spiral an anchor to a diseased native valve of a heart, comprising: an anchor control catheter; andan anchor guide extending from the anchor control catheter, the anchor guide comprising a flexible configuration with an elongate delivery geometry and a rigid configuration with a curved deployed geometry, the anchor guide in the rigid configuration comprises a proximal section, a middle section, and a distal section, wherein the proximal section comprises a straight central axis and extends from the anchor control catheter, the middle section spirals axially and radially outwards from the straight central axis, and the distal section curves concentrically about the straight central axis in a plane that is perpendicular to the straight central axis, wherein the anchor guide is shape-set to assume an intermediate configuration that has an intermediate geometry that is between the elongate delivery geometry and the curved deployed geometry.
  • 2. The delivery system of claim 1, wherein the anchor guide comprises a plurality of cuts configured to define a shape of the anchor guide in the rigid configuration.
  • 3. The delivery system of claim 2, wherein the plurality of cuts comprises window cuts, interlocking spiral cuts, or toothed wedge cuts.
  • 4. The delivery system of claim 1, further comprising one or more actuation elements configured to actuate the anchor guide from the flexible configuration to the rigid configuration.
  • 5. The delivery system of claim 4, wherein the one or more actuation elements comprises a nested concentric shaft mechanism or one or more pullwires or cables.
  • 6. The delivery system of claim 1, wherein the anchor guide comprises a shape memory material.
  • 7. The delivery system of claim 1, wherein the anchor guide comprises a central channel configured to hold the anchor therein.
  • 8. The delivery system of claim 7, wherein the anchor guide is configured to deflect the anchor positioned within the central channel when the anchor guide is transitioned from the flexible configuration to the rigid configuration.
  • 9. The delivery system of claim 8, wherein the anchor guide is configured to position the anchor concentrically relative to a central axis of the anchor control catheter.
  • 10. The delivery system of claim 1, wherein the anchor guide in the flexible configuration is configured to be positioned within a delivery sheath.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Patent Application No. 63/072,788, filed on Aug. 31, 2020, titled “VALVE DELIVERY SYSTEM,” the entirety of which is incorporated by reference herein.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2021/048472 8/31/2021 WO
Publishing Document Publishing Date Country Kind
WO2022/047393 3/3/2022 WO A
US Referenced Citations (588)
Number Name Date Kind
4725274 Lane et al. Feb 1988 A
5002563 Pyka et al. Mar 1991 A
5327905 Avitall Jul 1994 A
5356424 Buzerak et al. Oct 1994 A
5370685 Stevens Dec 1994 A
5582616 Bolduc et al. Dec 1996 A
5755601 Jones May 1998 A
5779669 Haissaguerre et al. Jul 1998 A
5873835 Hastings et al. Feb 1999 A
5944690 Falwell et al. Aug 1999 A
5997526 Giba et al. Dec 1999 A
6048339 Zirps et al. Apr 2000 A
6053873 Govari et al. Apr 2000 A
6254550 McNamara et al. Jul 2001 B1
6419695 Gabbay Jul 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6530952 Vesely Mar 2003 B2
6533783 Töllner Mar 2003 B1
6641553 Chee et al. Nov 2003 B1
6752813 Goldfarb et al. Jun 2004 B2
6908478 Alferness et al. Jun 2005 B2
6964684 Ortiz et al. Nov 2005 B2
6974476 McGuckin, Jr. et al. Dec 2005 B2
7077861 Spence Jul 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7160322 Gabbay Jan 2007 B2
7175656 Khairkhahan Feb 2007 B2
7201771 Lane Apr 2007 B2
7226467 Lucatero et al. Jun 2007 B2
7381219 Salahieh et al. Jan 2008 B2
7329279 Haug et al. Feb 2008 B2
7445631 Salahieh et al. Nov 2008 B2
7470285 Nugent et al. Dec 2008 B2
7527647 Spence May 2009 B2
7534261 Freidman May 2009 B2
7563267 Goldfarb et al. Jul 2009 B2
7594903 Webler et al. Sep 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7621948 Herrmann et al. Nov 2009 B2
7666204 Thornton et al. Feb 2010 B2
7704269 St. Goar et al. Apr 2010 B2
7731705 Wardle Jun 2010 B2
7748389 Salahich et al. Jul 2010 B2
7749266 Forster et al. Jul 2010 B2
7780725 Haug et al. Aug 2010 B2
7799069 Bailey et al. Sep 2010 B2
7811296 Goldfarb et al. Oct 2010 B2
7824442 Salahieh et al. Nov 2010 B2
7824443 Salahieh et al. Nov 2010 B2
7846203 Cribier Dec 2010 B2
7947075 Goetz et al. May 2011 B2
7951195 Antonsson et al. May 2011 B2
7959666 Salahleh et al. Jun 2011 B2
7988724 Salahieh et al. Aug 2011 B2
8021421 Fogarty et al. Sep 2011 B2
8052749 Salahieh et al. Nov 2011 B2
8052750 Tuval et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8070800 Lock et al. Dec 2011 B2
8075615 Eberhardt et al. Dec 2011 B2
8096985 Legaspi et al. Jan 2012 B2
8147541 Forster et al. Apr 2012 B2
8147542 Maisano et al. Apr 2012 B2
8182528 Salahieh et al. May 2012 B2
8216256 Raschdorf et al. Jul 2012 B2
8236049 Rowe et al. Aug 2012 B2
8241351 Cabiri Aug 2012 B2
8251977 Partlett Aug 2012 B2
8252050 Maisano et al. Aug 2012 B2
8287584 Salahleh et al. Oct 2012 B2
8313526 Hoffman et al. Nov 2012 B2
8323241 Salahleh et al. Dec 2012 B2
8323336 Hill et al. Dec 2012 B2
8328868 Paul et al. Dec 2012 B2
8343213 Salahieh et al. Jan 2013 B2
8348995 Tuval et al. Jan 2013 B2
8348996 Tuval et al. Jan 2013 B2
8366767 Zhang Feb 2013 B2
8403981 Forster et al. Mar 2013 B2
8403983 Quadri et al. Mar 2013 B2
8414643 Tuval et al. Apr 2013 B2
8414644 Quadri et al. Apr 2013 B2
8414645 Dwork et al. Apr 2013 B2
8425593 Braido et al. Apr 2013 B2
8449599 Chau et al. May 2013 B2
8454686 Alkhatib Jun 2013 B2
8465541 Dwork Jun 2013 B2
8500800 Maisano et al. Aug 2013 B2
8512401 Murray et al. Aug 2013 B2
8523881 Cabiri et al. Sep 2013 B2
8545553 Zipory et al. Oct 2013 B2
8556963 Tremulis et al. Oct 2013 B2
8562645 Stone et al. Oct 2013 B2
8562673 Yeung et al. Oct 2013 B2
8579962 Salahieh et al. Nov 2013 B2
8603157 Seguin et al. Dec 2013 B2
8603160 Salahieh et al. Dec 2013 B2
8623075 Murray et al. Jan 2014 B2
8628570 Seguin Jan 2014 B2
8641727 Starksen et al. Feb 2014 B2
8652202 Alon et al. Feb 2014 B2
8652203 Quadri et al. Feb 2014 B2
8657872 Seguin Feb 2014 B2
8685086 Navia et al. Apr 2014 B2
8696693 Najafi et al. Apr 2014 B2
8715342 Zipory et al. May 2014 B2
8740976 Tran et al. Jun 2014 B2
8784479 Antonsson et al. Jul 2014 B2
8790367 Nguyen et al. Jul 2014 B2
8808368 Maisano et al. Aug 2014 B2
8828078 Salahich et al. Sep 2014 B2
8834564 Tuval et al. Sep 2014 B2
8840663 Salahieh et al. Sep 2014 B2
8840664 Karapetian et al. Sep 2014 B2
8845588 Bruszewski Sep 2014 B2
8852271 Murray et al. Oct 2014 B2
8876893 Dwork et al. Nov 2014 B2
8876894 Tuval et al. Nov 2014 B2
8876895 Tuval et al. Nov 2014 B2
8900294 Paniagua et al. Dec 2014 B2
8911494 Hammer et al. Dec 2014 B2
8920369 Salahieh et al. Dec 2014 B2
8926690 Kowalsky Jan 2015 B2
8926696 Cabiri et al. Jan 2015 B2
8926697 Gross et al. Jan 2015 B2
8940002 Goertzen Jan 2015 B2
8940044 Hammer et al. Jan 2015 B2
8951299 Paul et al. Feb 2015 B2
8986371 Quill et al. Mar 2015 B2
8998980 Shipley et al. Apr 2015 B2
9005273 Salahleh et al. Apr 2015 B2
9011515 Schweich et al. Apr 2015 B2
9011523 Seguin Apr 2015 B2
9011530 Reich et al. Apr 2015 B2
9017408 Siegal et al. Apr 2015 B2
9023100 Quadri et al. May 2015 B2
9034032 McLean et al. May 2015 B2
9039757 McLean et al. May 2015 B2
9056009 Keränen Jun 2015 B2
9061120 Osypka et al. Jun 2015 B2
9095431 Yu et al. Aug 2015 B2
9119719 Zipory et al. Sep 2015 B2
9125739 Paniagua et al. Sep 2015 B2
9125740 Morriss et al. Sep 2015 B2
9155619 Liu et al. Oct 2015 B2
9168129 Valdez et al. Oct 2015 B2
9168131 Yohanan et al. Oct 2015 B2
9173713 Hart et al. Nov 2015 B2
9173737 Hill et al. Nov 2015 B2
9180006 Keränen Nov 2015 B2
9226823 Dwork Jan 2016 B2
9232995 Kovalsky et al. Jan 2016 B2
9277994 Miller et al. Mar 2016 B2
9289297 Wilson et al. Mar 2016 B2
9295547 Costello et al. Mar 2016 B2
9301756 Wardle Apr 2016 B2
9301836 Buchbinder et al. Apr 2016 B2
9320597 Savage et al. Apr 2016 B2
9343224 Zilbershlag May 2016 B2
9358110 Paul et al. Jun 2016 B2
9414915 Lombardi et al. Aug 2016 B2
9427315 Schweich et al. Aug 2016 B2
9439757 Wallace et al. Sep 2016 B2
9468525 Kovalsky Oct 2016 B2
9474606 Zipory et al. Oct 2016 B2
9474840 Siess Oct 2016 B2
9480559 Vidlund et al. Nov 2016 B2
9492273 Wallace et al. Nov 2016 B2
9526487 Rahmani Dec 2016 B2
9526609 Salahieh et al. Dec 2016 B2
9532868 Braido Jan 2017 B2
9532870 Cooper et al. Jan 2017 B2
9561102 Rust et al. Feb 2017 B2
9579198 Deem et al. Feb 2017 B2
9636224 Zipory et al. May 2017 B2
9636481 Campbell et al. May 2017 B2
9662202 Quill et al. May 2017 B2
9662206 Börtlein et al. May 2017 B2
9662209 Gross et al. May 2017 B2
9675454 Vidlund et al. Jun 2017 B2
9681952 Hacohen et al. Jun 2017 B2
9687343 Börtlein et al. Jun 2017 B2
9724192 Sheps et al. Aug 2017 B2
9730790 Quadri et al. Aug 2017 B2
9730793 Reich et al. Aug 2017 B2
9744031 Girard et al. Aug 2017 B2
9744038 Dahlgren et al. Aug 2017 B2
9750605 Ganesan et al. Sep 2017 B2
9763779 Börtlein et al. Sep 2017 B2
9763780 Morriss et al. Sep 2017 B2
9814611 Cartledge et al. Nov 2017 B2
9827090 Hill et al. Nov 2017 B2
9861480 Zakai et al. Jan 2018 B2
9867700 Bakis et al. Jan 2018 B2
9867702 Keränen et al. Jan 2018 B2
9877833 Bishop et al. Jan 2018 B1
9883941 Hastings et al. Feb 2018 B2
9889003 Börtlein et al. Feb 2018 B2
9895221 Vidlund Feb 2018 B2
9895222 Zeng et al. Feb 2018 B2
9901444 Valdez et al. Feb 2018 B2
9918840 Reich et al. Mar 2018 B2
D815744 Ratz et al. Apr 2018 S
9949825 Braido et al. Apr 2018 B2
9949828 Sheps et al. Apr 2018 B2
9950142 Eversull et al. Apr 2018 B2
9968452 Sheps et al. May 2018 B2
9974647 Ganesan et al. May 2018 B2
9974650 Nguyen-Thien-Nhon et al. May 2018 B2
9999504 Czyscon et al. Jun 2018 B2
10004599 Rabito et al. Jun 2018 B2
10016271 Morriss et al. Jul 2018 B2
10016272 Spence et al. Jul 2018 B2
10028832 Quill et al. Jul 2018 B2
10029037 Muller et al. Jul 2018 B2
10034747 Harewood Jul 2018 B2
10034749 Spence et al. Jul 2018 B2
10039637 Maimon et al. Aug 2018 B2
10045846 Bonyuet et al. Aug 2018 B2
10052198 Chau et al. Aug 2018 B2
10052199 Spence et al. Aug 2018 B2
10058318 Tegzes Aug 2018 B2
10058321 Sampson et al. Aug 2018 B2
10064719 Börtlein et al. Sep 2018 B2
10070954 Braido et al. Sep 2018 B2
10092400 Jimenez et al. Oct 2018 B2
10098734 Hoang Oct 2018 B2
10105217 Keränen Oct 2018 B2
10105224 Buchbinder et al. Oct 2018 B2
10130464 Meiri et al. Nov 2018 B2
10130471 Keränen et al. Nov 2018 B2
10143552 Wallace et al. Dec 2018 B2
10149759 Naor Dec 2018 B2
10172708 Anderson Jan 2019 B2
10172711 Keränen Jan 2019 B2
10179042 Braido et al. Jan 2019 B2
10195021 Keränen et al. Feb 2019 B2
10195025 Levi et al. Feb 2019 B2
10195027 Nasr Feb 2019 B2
10195028 Hosmer et al. Feb 2019 B2
10195029 Keränen Feb 2019 B2
10201418 Biadillah et al. Feb 2019 B2
10206775 Kovalsky et al. Feb 2019 B2
10213307 Dwork et al. Feb 2019 B2
10226330 Spence et al. Mar 2019 B2
10226334 Rowe et al. Mar 2019 B2
10238489 Conklin Mar 2019 B2
10251749 Zerkowski et al. Apr 2019 B2
10258464 Delaloye et al. Apr 2019 B2
10258468 Deem et al. Apr 2019 B2
10265169 Desrosiers et al. Apr 2019 B2
10271950 Neustadter Apr 2019 B2
10299917 Morriss et al. May 2019 B2
10299921 Dale et al. May 2019 B2
10314701 Von Segesser et al. Jun 2019 B2
10321988 Gorman et al. Jun 2019 B2
10321989 Keränen Jun 2019 B2
10327743 St. Goar et al. Jun 2019 B2
10327766 Zerkowski et al. Jun 2019 B2
10335277 Crisostomo et al. Jul 2019 B2
10338724 Zhao Jul 2019 B2
10350066 Cooper et al. Jul 2019 B2
10357351 Cooper et al. Jul 2019 B2
10357634 Simmons et al. Jul 2019 B2
10363130 Armer et al. Jul 2019 B2
10363131 Eidenschink et al. Jul 2019 B2
10368986 Gosal et al. Aug 2019 B2
10368990 Noe et al. Aug 2019 B2
10376266 Herman et al. Aug 2019 B2
10376360 Bruchman et al. Aug 2019 B2
10376363 Quadri et al. Aug 2019 B2
10398547 Li et al. Sep 2019 B2
10426608 Salahieh et al. Oct 2019 B2
10433961 McLean Oct 2019 B2
10470881 Noe et al. Nov 2019 B2
10478291 Nguyen et al. Nov 2019 B2
10500048 Khairkhahan et al. Dec 2019 B2
10507104 Zhang et al. Dec 2019 B2
10512541 Zerkowski et al. Dec 2019 B2
10524901 Quadri et al. Jan 2020 B2
10548729 Zipory et al. Feb 2020 B2
10568737 Noe et al. Feb 2020 B2
10575951 Johnson et al. Mar 2020 B2
10603165 Maimon et al. Mar 2020 B2
10639154 Seguin May 2020 B2
10653524 Khairkhahan et al. May 2020 B2
10660753 Pham et al. May 2020 B2
10687938 Patel et al. Jun 2020 B2
10695160 Lashinski et al. Jun 2020 B2
10702386 Khairkhahan et al. Jul 2020 B2
10709552 Backus et al. Jul 2020 B2
10716662 Delaloye et al. Jul 2020 B2
10722352 Spence Jul 2020 B2
10722353 Levi Jul 2020 B2
10729542 Howard et al. Aug 2020 B2
10743991 Brown Aug 2020 B2
10751180 Schewel Aug 2020 B2
10751184 Reich et al. Aug 2020 B2
10765514 Iflah et al. Sep 2020 B2
10813749 Nguyen et al. Oct 2020 B2
10828153 Noe et al. Nov 2020 B2
10856970 Tuval et al. Dec 2020 B2
10869755 Granada et al. Dec 2020 B2
10888420 Bateman et al. Jan 2021 B2
10912644 Argento et al. Feb 2021 B2
10973629 Levi et al. Apr 2021 B2
10973630 Torrianni et al. Apr 2021 B2
11007057 Pham et al. May 2021 B2
11020221 Arcaro et al. Jun 2021 B2
11039922 Konno Jun 2021 B2
11471282 Argento et al. Oct 2022 B2
11672657 Argento et al. Jun 2023 B2
20020173841 Ortiz et al. Nov 2002 A1
20030114913 Spenser et al. Jun 2003 A1
20030233142 Morales et al. Dec 2003 A1
20040039442 St. Goar et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahich et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137696 Salahleh et al. Jun 2005 A1
20050165344 Dobak, III Jul 2005 A1
20050240202 Shennib et al. Oct 2005 A1
20050277839 Alderman et al. Dec 2005 A1
20060009841 McGuckin, Jr. et al. Jan 2006 A1
20060052821 Abbot et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060178700 Quinn Aug 2006 A1
20060217762 Maahs et al. Sep 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060293698 Douk Dec 2006 A1
20070051377 Douk et al. Mar 2007 A1
20070055206 To et al. Mar 2007 A1
20070118151 Davidson May 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070185572 Solem et al. Aug 2007 A1
20070255396 Douk et al. Nov 2007 A1
20070293724 Saadat et al. Dec 2007 A1
20070293943 Quinn Dec 2007 A1
20080004696 Vesely Jan 2008 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080200980 Robin et al. Aug 2008 A1
20080208327 Rowe Aug 2008 A1
20080275503 Spence et al. Nov 2008 A1
20080275540 Wen Nov 2008 A1
20090093826 Warder-Gabaldon Apr 2009 A1
20090138079 Tuval et al. May 2009 A1
20090192601 Rafiee et al. Jul 2009 A1
20090209950 Starksen Aug 2009 A1
20090222026 Rothstein et al. Sep 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20100010520 Takahashi et al. Jan 2010 A1
20100049239 McGuckin, Jr. et al. Feb 2010 A1
20100076497 Zwirkoski Mar 2010 A1
20100094406 Leprince et al. Apr 2010 A1
20100185172 Fabro Jul 2010 A1
20100198056 Fabro et al. Aug 2010 A1
20100198192 Serina et al. Aug 2010 A1
20100198208 Napp et al. Aug 2010 A1
20100217385 Thompson et al. Aug 2010 A1
20100312333 Navia et al. Dec 2010 A1
20110022164 Quinn et al. Jan 2011 A1
20110046600 Crank Feb 2011 A1
20110224785 Hacohen Sep 2011 A1
20110288637 De Marchena Nov 2011 A1
20110313515 Quadri et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20120022633 Olson et al. Jan 2012 A1
20120053680 Bolling et al. Mar 2012 A1
20120143316 Seguin et al. Jun 2012 A1
20120197388 Khairkhahan et al. Aug 2012 A1
20120203333 McGuckin, Jr. et al. Aug 2012 A1
20120221101 Moaddeb et al. Aug 2012 A1
20120277853 Rothstein Nov 2012 A1
20130006352 Yaron Jan 2013 A1
20130023985 Khairkhahan et al. Jan 2013 A1
20130035758 Seguin et al. Feb 2013 A1
20130079873 Migliazza et al. Mar 2013 A1
20130123912 Tung et al. May 2013 A1
20130172992 Gross et al. Jul 2013 A1
20130253643 Rolando et al. Sep 2013 A1
20130274873 Delaloye et al. Oct 2013 A1
20130325110 Khalil et al. Dec 2013 A1
20140005768 Thomas et al. Jan 2014 A1
20140031928 Murphy et al. Jan 2014 A1
20140081154 Toth May 2014 A1
20140200649 Essinger et al. Jul 2014 A1
20140228943 Stigall et al. Aug 2014 A1
20140249621 Eidenschink Sep 2014 A1
20140257467 Lane et al. Sep 2014 A1
20140277382 Dolan et al. Sep 2014 A1
20140277409 Börtlein et al. Sep 2014 A1
20140324163 Keränen et al. Oct 2014 A1
20140379074 Spence et al. Dec 2014 A1
20150005764 Hanson et al. Jan 2015 A1
20150018876 Ewers et al. Jan 2015 A1
20150051709 Vasquez et al. Feb 2015 A1
20150134055 Spence et al. May 2015 A1
20150173897 Raanani et al. Jun 2015 A1
20150250480 Featherstone Sep 2015 A1
20150265403 Keränen Sep 2015 A1
20150272737 Dale et al. Oct 2015 A1
20150297346 Duffy et al. Oct 2015 A1
20150305863 Gray et al. Oct 2015 A1
20150328000 Ratz et al. Nov 2015 A1
20150335290 Hunter Nov 2015 A1
20150351735 Keränen et al. Dec 2015 A1
20150351908 Keränen et al. Dec 2015 A1
20150351911 Keränen et al. Dec 2015 A1
20160089126 Guo Mar 2016 A1
20160095705 Keränen et al. Apr 2016 A1
20160113764 Sheahan et al. Apr 2016 A1
20160143689 Ditter May 2016 A1
20160143731 Backus et al. May 2016 A1
20160166380 Seguin et al. Jun 2016 A1
20160206853 Bolduc Jul 2016 A1
20160228247 Maimon et al. Aug 2016 A1
20160235526 Lashinski et al. Aug 2016 A1
20160235529 Ma et al. Aug 2016 A1
20160324637 Hlavka et al. Nov 2016 A1
20160324639 Nguyen et al. Nov 2016 A1
20160331523 Chau et al. Nov 2016 A1
20160346080 Righini et al. Dec 2016 A1
20170056163 Tayeb et al. Mar 2017 A1
20170071732 Conklin et al. Mar 2017 A1
20170079790 Vidlund et al. Mar 2017 A1
20170112624 Patel Apr 2017 A1
20170119524 Salahieh et al. May 2017 A1
20170128203 Zhang et al. May 2017 A1
20170156723 Keating et al. Jun 2017 A1
20170165057 Morriss et al. Jun 2017 A9
20170189177 Schweich et al. Jul 2017 A1
20170216025 Nitzan et al. Aug 2017 A1
20170245850 Call et al. Aug 2017 A1
20170258585 Marquez et al. Sep 2017 A1
20170273788 O'Carroll et al. Sep 2017 A1
20170273789 Yaron et al. Sep 2017 A1
20170281341 Lim et al. Oct 2017 A1
20170311937 Bambury et al. Nov 2017 A1
20170348099 Mendelson et al. Dec 2017 A1
20180049873 Manash et al. Feb 2018 A1
20180055628 Patel et al. Mar 2018 A1
20180092763 Dagan et al. Apr 2018 A1
20180110622 Gregg et al. Apr 2018 A1
20180116790 Ratz et al. May 2018 A1
20180133003 Levi May 2018 A1
20180177592 Benichou et al. Jun 2018 A1
20180177594 Patel et al. Jun 2018 A1
20180206982 Haivatov et al. Jul 2018 A1
20180206986 Noe et al. Jul 2018 A1
20180206992 Brown Jul 2018 A1
20180207395 Bulman et al. Jul 2018 A1
20180214267 Lally et al. Aug 2018 A1
20180214270 Subramanian et al. Aug 2018 A1
20180221014 Darabian Aug 2018 A1
20180228608 Sheps et al. Aug 2018 A1
20180228610 Lashinski et al. Aug 2018 A1
20180235443 Smith et al. Aug 2018 A1
20180250126 O'Connor et al. Sep 2018 A1
20180250132 Ketai et al. Sep 2018 A1
20180263764 Manash et al. Sep 2018 A1
20180289473 Rajagopal et al. Oct 2018 A1
20180289474 Rajagopal et al. Oct 2018 A1
20180289478 Quill Oct 2018 A1
20180289480 D'ambra et al. Oct 2018 A1
20180289485 Rajagopal et al. Oct 2018 A1
20180296335 Miyashiro Oct 2018 A1
20180296338 Rabito et al. Oct 2018 A1
20180318079 Patel Nov 2018 A1
20180325665 Gurovich et al. Nov 2018 A1
20180333259 Dibie Nov 2018 A1
20180344303 Bambury et al. Dec 2018 A1
20180344454 Mauch et al. Dec 2018 A1
20180344459 Spence et al. Dec 2018 A1
20180360600 Zhuang et al. Dec 2018 A1
20180368830 O'Carroll et al. Dec 2018 A1
20190000615 Tayeb et al. Jan 2019 A1
20190000625 O'Carroll et al. Jan 2019 A1
20190008635 Francis et al. Jan 2019 A1
20190008639 Landon et al. Jan 2019 A1
20190008640 Cooper et al. Jan 2019 A1
20190015205 Rajagopal et al. Jan 2019 A1
20190021859 O'Carrol et al. Jan 2019 A1
20190046315 Gao et al. Feb 2019 A1
20190053894 Levi et al. Feb 2019 A1
20190053895 Levi Feb 2019 A1
20190053898 Maimon et al. Feb 2019 A1
20190053899 Levi Feb 2019 A1
20190053903 Rohl et al. Feb 2019 A1
20190060068 Cope et al. Feb 2019 A1
20190060069 Maimon et al. Feb 2019 A1
20190060071 Lane et al. Feb 2019 A1
20190076244 Yohanan et al. Mar 2019 A1
20190076664 Ollivier Mar 2019 A1
20190117392 Quadri et al. Apr 2019 A1
20190133756 Zhang et al. May 2019 A1
20190133757 Zhang et al. May 2019 A1
20190142589 Basude May 2019 A1
20190159770 Rohl et al. May 2019 A1
20190160292 Peichel et al. May 2019 A1
20190167425 Reich et al. Jun 2019 A1
20190183649 Allen et al. Jun 2019 A1
20190192296 Schwartz et al. Jun 2019 A1
20190201191 McLean et al. Jul 2019 A1
20190209311 Zhang et al. Jul 2019 A1
20190209312 Zhang et al. Jul 2019 A1
20190209313 Zhang et al. Jul 2019 A1
20190209314 Zhang et al. Jul 2019 A1
20190209315 Zhang et al. Jul 2019 A1
20190209316 Zhang et al. Jul 2019 A1
20190209317 Zhang et al. Jul 2019 A1
20190209318 Zhang et al. Jul 2019 A1
20190209320 Draster et al. Jul 2019 A1
20190231520 Desrosiers et al. Aug 2019 A1
20190240023 Spence et al. Aug 2019 A1
20190246916 Kuraguntla et al. Aug 2019 A1
20190254816 Anderson et al. Aug 2019 A1
20190261995 Goldfarb et al. Aug 2019 A1
20190261996 Goldfarb et al. Aug 2019 A1
20190261997 Goldfarb et al. Aug 2019 A1
20190262129 Cooper et al. Aug 2019 A1
20190282237 Goldfarb et al. Sep 2019 A1
20190328518 Neumann Oct 2019 A1
20190336282 Christianson et al. Nov 2019 A1
20190343625 Gharib et al. Nov 2019 A1
20190365530 Hoang et al. Dec 2019 A1
20190374337 Zamani et al. Dec 2019 A1
20190374342 Gregg et al. Dec 2019 A1
20200000579 Manash et al. Jan 2020 A1
20200000586 Tian et al. Jan 2020 A1
20200008936 Cheema et al. Jan 2020 A1
20200022811 Griswold et al. Jan 2020 A1
20200054453 Zerkowski et al. Feb 2020 A1
20200060813 Nguyen et al. Feb 2020 A1
20200060820 Ben-Zvi et al. Feb 2020 A1
20200060852 Argento et al. Feb 2020 A1
20200078000 Rajagopal et al. Mar 2020 A1
20200093601 Neustadter Mar 2020 A1
20200107932 Rabito Apr 2020 A1
20200107933 Oba Apr 2020 A1
20200113586 Karasic et al. Apr 2020 A1
20200113685 Miller et al. Apr 2020 A1
20200113696 Ekvall et al. Apr 2020 A1
20200138575 Tuval May 2020 A1
20200139082 Matlock May 2020 A1
20200178977 Coleman et al. Jun 2020 A1
20200188107 Gloss et al. Jun 2020 A1
20200205800 Gilmore et al. Jul 2020 A1
20200205969 Hacohen Jul 2020 A1
20200205974 Zerkowski et al. Jul 2020 A1
20200205975 Khairkhahan Jul 2020 A1
20200205979 O'Carroll et al. Jul 2020 A1
20200214708 Sharma Jul 2020 A1
20200229806 Goldfarb et al. Jul 2020 A1
20200229918 Pham et al. Jul 2020 A1
20200261220 Argento et al. Aug 2020 A1
20200275921 Gilmore et al. Sep 2020 A1
20200276017 Subramanian et al. Sep 2020 A1
20200297489 Bishop et al. Sep 2020 A1
20200352705 Heneghan et al. Nov 2020 A1
20200352706 Campbell Nov 2020 A1
20200360139 Hammer et al. Nov 2020 A1
20210022854 Zhao et al. Jan 2021 A1
20210022860 Lally et al. Jan 2021 A1
20210030536 Kaleta Feb 2021 A1
20210121289 Bruchman et al. Apr 2021 A1
20210128297 Braido et al. May 2021 A1
20210145573 Dasi et al. May 2021 A1
20210161688 Shahriari Jun 2021 A1
20210177583 Colavito et al. Jun 2021 A1
20210177584 Levi et al. Jun 2021 A1
20210177587 Braido Jun 2021 A1
20210186689 Eidenschink et al. Jun 2021 A1
20210228343 Scheinblum et al. Jul 2021 A1
20210378823 Argento et al. Dec 2021 A1
20210401572 Nasar et al. Dec 2021 A1
20220054261 Argento et al. Feb 2022 A1
20220175522 Salahieh et al. Jun 2022 A1
20220257373 Yang et al. Aug 2022 A1
20220401214 Saul Dec 2022 A1
20230044256 Salahleh Feb 2023 A1
20230105492 Argento et al. Apr 2023 A1
20230118748 Argento Apr 2023 A1
20230165679 Boyd et al. Jun 2023 A1
Foreign Referenced Citations (127)
Number Date Country
2012261727 Oct 2015 AU
2019246822 Aug 2020 AU
2020227034 Sep 2020 AU
PI0820603 Jun 2020 BR
2979817 Sep 2016 CA
2954826 Oct 2019 CA
103764216 Apr 2014 CN
103974670 Aug 2014 CN
105358098 Feb 2016 CN
111110401 May 2020 CN
111110403 May 2020 CN
108601655 Jun 2020 CN
111265335 Jun 2020 CN
111278389 Jun 2020 CN
111329541 Jun 2020 CN
19857887 May 2005 DE
102014102650 Sep 2015 DE
1432369 Feb 2008 EP
2374415 Oct 2011 EP
2907479 Aug 2015 EP
3037064 Jun 2016 EP
3342355 Jul 2018 EP
3395296 Oct 2018 EP
3406225 Nov 2018 EP
3417831 Dec 2018 EP
3476366 May 2019 EP
3482718 May 2019 EP
2637607 Oct 2019 EP
3554424 Oct 2019 EP
3244809 Feb 2020 EP
3639792 Apr 2020 EP
3417831 May 2020 EP
3649963 May 2020 EP
2072027 Jun 2020 EP
3441045 Jul 2020 EP
3672528 Jul 2020 EP
3554423 Aug 2020 EP
3107498 Sep 2020 EP
3570782 Sep 2020 EP
3700467 Sep 2020 EP
3705090 Sep 2020 EP
3782585 Feb 2021 EP
H08131551 May 1996 JP
2004154177 Jun 2004 JP
2008018139 Jan 2008 JP
2011506017 Mar 2011 JP
2012531270 Dec 2012 JP
2020515375 May 2020 JP
2020517379 Jun 2020 JP
2020520729 Jul 2020 JP
6735294 Aug 2020 JP
2020032237 Mar 2020 KR
2020033349 Mar 2020 KR
2020033350 Mar 2020 KR
202027694 Aug 2020 TW
WO2007007873 Jan 2007 WO
WO2007081820 Jul 2007 WO
WO2010141847 Dec 2010 WO
WO2011025945 Mar 2011 WO
WO2012087842 Jun 2012 WO
WO2012145545 Oct 2012 WO
WO2013190910 Dec 2013 WO
WO2015127264 Aug 2015 WO
WO2015173609 Nov 2015 WO
WO2015195823 Dec 2015 WO
WO2016052145 Apr 2016 WO
WO2016117169 Jul 2016 WO
WO2016183485 Nov 2016 WO
WO2017121193 Jul 2017 WO
WO2017151566 Sep 2017 WO
WO2017214098 Dec 2017 WO
WO2018025260 Feb 2018 WO
WO2018039561 Mar 2018 WO
WO2018039589 Mar 2018 WO
WO2018112429 Jun 2018 WO
WO2018119304 Jun 2018 WO
WO2018178966 Oct 2018 WO
WO2018178967 Oct 2018 WO
WO2018187390 Oct 2018 WO
WO2018192197 Oct 2018 WO
WO2019010370 Jan 2019 WO
WO2019036592 Feb 2019 WO
WO2019062366 Apr 2019 WO
WO2019081777 May 2019 WO
WO2019086958 May 2019 WO
WO2019102484 May 2019 WO
WO2019116369 Jun 2019 WO
WO2019118371 Jun 2019 WO
WO2019135011 Jul 2019 WO
WO2019135028 Jul 2019 WO
WO2019144036 Jul 2019 WO
WO2019147504 Aug 2019 WO
WO2019147846 Aug 2019 WO
WO2019154124 Aug 2019 WO
WO2019164516 Aug 2019 WO
WO2019195860 Oct 2019 WO
WO2019209927 Oct 2019 WO
WO2019222694 Nov 2019 WO
WO2019241777 Dec 2019 WO
WO2020051147 Mar 2020 WO
WO2020051591 Mar 2020 WO
WO2020072199 Apr 2020 WO
WO2020072201 Apr 2020 WO
WO2020073050 Apr 2020 WO
WO2020123719 Jun 2020 WO
WO2020132590 Jun 2020 WO
WO2020157018 Aug 2020 WO
WO2020163112 Aug 2020 WO
WO2020236830 Nov 2020 WO
WO2020247907 Dec 2020 WO
WO2021021482 Feb 2021 WO
WO2021028867 Feb 2021 WO
WO2021034497 Feb 2021 WO
WO2021086850 May 2021 WO
WO2021091754 May 2021 WO
WO2021113143 Jun 2021 WO
WO2021178560 Sep 2021 WO
WO2021183610 Sep 2021 WO
WO2021257278 Dec 2021 WO
WO2021257722 Dec 2021 WO
WO2022010974 Jan 2022 WO
WO2022046678 Mar 2022 WO
WO2022047095 Mar 2022 WO
WO2022047160 Mar 2022 WO
WO2022047274 Mar 2022 WO
WO2022047393 Mar 2022 WO
WO2022047395 Mar 2022 WO
Non-Patent Literature Citations (15)
Entry
Schaefer; Large heart valves—small heart valves; ISMAAP; Oct. 19, 2015; 5 pages; retrieved from the internet (https://www.ismaap.org/condition-detail/large-heart-valves-small-heart-valves/) on Mar. 21, 2023.
Argento et al.; U.S. Appl. No. 17/931,408 entitled “Prosthetic cardiac valve devices, systems, and methods,”, filed Sep. 12, 2022.
Argento et al.; U.S. Appl. No. 18/002,219 entitled “Minimal frame prosthetic cardiac valve delivery devices, systems, and methods,”, filed Dec. 16, 2022.
Backus et al.; U.S. Appl. No. 18/004,609 entitled “Valve delivery system,” filed Jan. 6, 2023.
Mulcahy et al.; U.S. Appl. No. 18/043,480 entitled “Prosthetic cardiac valve delivery devices, systems, and methods,”, filed Feb. 28, 2023.
Adamek-Bowers et al.; U.S. Appl. No. 18/043,499 entitled “Interface for prosthetic cardiac valve and delivery systems,”, filed Feb. 28, 2023.
Salahieh et al.; U.S. Appl. No. 18/043,519 entitled “Flared prosthetic cardiac valve delivery devices and systems,”, filed Feb. 28, 2023.
Scott et al.; U.S. Appl. No. 18/043,526 entitled “Access sheath for prosthetic cardiac valve delivery systems,”, filed Feb. 28, 2023.
Yang et al.; U.S. Appl. No. 18/043,542 entitled “Anchor for prosthetic cardiac valve devices,”, filed Feb. 28, 2023.
Argento et al.; U.S. Appl. No. 18/246,307 entitled “Systems, methods, and devices for expandable sensors,”, filed Mar. 22, 2023.
Argento et al.; U.S. Appl. No. 18/246,311 entitled “Prosthetic cardiac valve sensor devices, systems, and methods with imaging,” filed Mar. 22, 2023.
Westaby et al.; Adult human valve dimensions and their surgical significance; The American Journal of Cardiology; 53(4); pp. 552-556; Feb. 1984.
Argento et al.; U.S. Appl. No. 18/185,330 entitled “Prosthetic cardiac valve devices, systems, and methods,”, filed Mar. 16, 2023.
Adamek-Bowers et al.; U.S. Appl. No. 18/255,763 entitled “Mitral valve implants,”, filed Jun. 2, 2023.
Argento et al.; U.S. Appl. No. 18/494,520 entitled “Prosthetic cardiac valve devices, systems, and methods,”, filed Oct. 25, 2023.
Related Publications (1)
Number Date Country
20230310147 A1 Oct 2023 US
Provisional Applications (1)
Number Date Country
63072788 Aug 2020 US